Assignee
PROTEOSYS AG
DE·8 granted patents·11 pending applications·21 citations·filing 2001–2014
Top patents by PatentIndex Score
19 records- 0182US7732148B2Annexin A3 for prostate cancer diagnosisPROTEOSYS AG·Filed 2006·Granted Jun 8, 2010·10 cites·8 claims
- 0281US8039464B2Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseasesPROTEOSYS AG·Filed 2005·Granted Oct 18, 2011·5 cites·7 claims
- 0376US8012697B2Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinomaPROTEOSYS AG·Filed 2007·Granted Sep 6, 2011·3 cites·18 claims
- 0473US7538197B2Use of neuregulin-β as an indicator and/or targetPROTEOSYS AG·Filed 2001·Granted May 26, 2009·2 cites·5 claims
- 0568US7998970B2Use of finasteride, dutasteride and related compounds for the prevention or treatment of neurologically-associated disordersPROTEOSYS AG·Filed 2005·Granted Aug 16, 2011·1 cites·11 claims
- 0666US2010256066A1Active soluble post-translationally modified neuregulin isoformsPROTEOSYS AG·Filed 2008·Application pending·0 cites
- 0764US2014243269A1Method of effecting neuroprotection using soluble neuregulin isoformsPROTEOSYS AG·Filed 2014·Application pending·0 cites
- 0864US2014323408A1Method of inhibiting dopaminergic cell deathPROTEOSYS AG·Filed 2014·Application pending·0 cites
- 0964US2014243270A1Pharmaceutical composition containing neuregulin isoformsPROTEOSYS AG·Filed 2014·Application pending·0 cites
- 1055US8377648B2Autoimmune regulation of prostate cancer by annexin A3PROTEOSYS AG·Filed 2008·Granted Feb 19, 2013·0 cites·16 claims
- 1150US2011143366A1Protein biomarkers for in vitro testing of developmental toxicity and enbryotoxicity of chemical substancesPROTEOSYS AG·Filed 2009·Application pending·0 cites
- 1250US2014271922A1Pirenzepine as an agent in cancer treatmentPROTEOSYS AG·Filed 2013·Application pending·0 cites
- 1349US2007298448A1Enrichment of Enzymatic Cleavage ProductsPROTEOSYS AG·Filed 2004·Application pending·0 cites
- 1445US2009318354A1Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1)PROTEOSYS AG·Filed 2007·Application pending·0 cites
- 1542US2011177536A1Novel antibodies recognizing native annexin a3PROTEOSYS AG·Filed 2009·Application pending·0 cites
- 1635US7824923B2Neuregulin-β isoforms associated with neuronal processesPROTEOSYS AG·Filed 2002·Granted Nov 2, 2010·0 cites·2 claims
- 1734US2011263574A1Pirenzepine as otoprotective agentPROTEOSYS AG·Filed 2010·Application pending·0 cites
- 1833US7759068B2Use of substances for treating tumorsPROTEOSYS AG·Filed 2003·Granted Jul 20, 2010·0 cites·1 claims
- 1930US2007172900A1Diagnostic marker for cancerPROTEOSYS AG·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROTEOSYS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →